These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32182109)

  • 1. Excessive Cyclosporine-Associated Immunosuppression in a Dog Heterozygous for the MDR1 (ABCB1-1Δ) Mutation.
    Mackin AJ; Riggs C; Beatty T; Mealey K; Boothe D; Archer T
    J Am Anim Hosp Assoc; 2020; 56(3):190. PubMed ID: 32182109
    [No Abstract]   [Full Text] [Related]  

  • 2. Gingival overgrowth in a dog that received long-term cyclosporine for immune-mediated hemolytic anemia.
    Namikawa K; Maruo T; Honda M; Hirata H; Lynch J; Madarame H
    Can Vet J; 2012 Jan; 53(1):67-70. PubMed ID: 22753966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients.
    Kotowski MJ; Bogacz A; Bartkowiak-Wieczorek J; Tejchman K; Dziewanowski K; Ostrowski M; Czerny B; Grześkowiak E; Machaliński B; Sieńko J
    Ann Transplant; 2019 Feb; 24():108-114. PubMed ID: 30799432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the ABCB1-1Δ gene mutation in a sample of New Zealand Huntaway dogs.
    Gedye K; Poole-Crowe E; Shepherd M; Wilding A; Parton K; Lopez-Villalobos N; Cave N
    N Z Vet J; 2023 May; 71(3):133-136. PubMed ID: 36786530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breed is associated with the ABCB1-1Δ mutation in Australian dogs.
    Soussa RW; Woodward A; Marty M; Cannon CM
    Aust Vet J; 2020 Mar; 98(3):79-83. PubMed ID: 31743433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain abscess in a dog immunosuppressed using cyclosporin.
    Smith PM; Haughland SP; Jeffery ND
    Vet J; 2007 May; 173(3):675-8. PubMed ID: 16690333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR1 gene polymorphism in allogeenic kidney transplant patients with tremor.
    Kotrych K; Domański L; Górnik W; Droździk M
    Pharmacol Rep; 2005; 57(2):241-5. PubMed ID: 15886424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous nocardiosis in two dogs receiving ciclosporin therapy for the management of canine atopic dermatitis.
    Siak MK; Burrows AK
    Vet Dermatol; 2013 Aug; 24(4):453-6, e102-3. PubMed ID: 23781943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation.
    Bouamar R; Hesselink DA; van Schaik RH; Weimar W; Macphee IA; de Fijter JW; van Gelder T
    Ther Drug Monit; 2011 Apr; 33(2):178-84. PubMed ID: 21383650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic Invasive Cutaneous Fungal Infections Associated with Administration of Cyclosporine to Dogs with Immune-mediated Disease.
    McAtee BB; Cummings KJ; Cook AK; Lidbury JA; Heseltine JC; Willard MD
    J Vet Intern Med; 2017 Nov; 31(6):1724-1729. PubMed ID: 28887897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MDR1 C3435T polymorphism: effects on P-glycoprotein expression/function and clinical significance.
    Dresser MJ
    AAPS PharmSci; 2001; 3(3):4-6. PubMed ID: 11783426
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia.
    Goggs R
    Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1327-1349. PubMed ID: 32814628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1-1Δ.
    Heit MC; Mealey KL; King SB
    J Vet Pharmacol Ther; 2021 Sep; 44(5):705-713. PubMed ID: 34219249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
    Chiodini B; Bassan R; Barbui T
    Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
    Crettol S; Venetz JP; Fontana M; Aubert JD; Pascual M; Eap CB
    Ther Drug Monit; 2008 Dec; 30(6):689-99. PubMed ID: 18978522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PREVALENCE OF THE
    Stafford EG; Harrison T; Kortum A; Mealey KL
    J Zoo Wildl Med; 2021 Jan; 51(4):1007-1011. PubMed ID: 33480582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis].
    Fukudo M
    Yakugaku Zasshi; 2007 Jul; 127(7):1081-9. PubMed ID: 17603267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance gene MDR1 expression: a gene transfection in vitro model and clinical analysis in cyclosporine-treated patients rejecting their renal grafts.
    Zanker B; Barth C; Stachowski J; Baldamus CA; Land W
    Transplant Proc; 1997; 29(1-2):1507-8. PubMed ID: 9123401
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymorphism in the P-glycoprotein drug transporter MDR1 gene in renal transplant patients treated with cyclosporin A in a Polish population.
    Kotrych K; Sulikowski T; Domański L; Białecka M; Droździk M
    Pharmacol Rep; 2007; 59(2):199-205. PubMed ID: 17556798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs.
    Adamo FP; O'Brien RT
    J Am Vet Med Assoc; 2004 Oct; 225(8):1211-6, 1196. PubMed ID: 15521442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.